Most revision cycles in pharmaceutical video production don't happen because the content is wrong — they happen because compliance wasn't considered early enough. Here's how to structure your video projects to get MLR approval on the first pass, more often.
Why MLR Review Is Different for Video
Unlike static assets like brochures or slide decks, video content introduces unique challenges for Medical, Legal, and Regulatory reviewers. Timing, voiceover pacing, on-screen supers, b-roll selection, and even music choices can all raise compliance flags that don't exist in print.
The most common mistake we see is teams treating MLR review as a post-production checkpoint — something to deal with after the creative is locked. By then, structural changes are expensive and time-consuming. The better approach is to build compliance awareness into every phase of production.
At Pharmhouse, we've seen first-pass MLR approval rates above 90% on projects where compliance was integrated from the scripting phase — compared to under 50% when it was addressed only in post-production.
Start With the Script, Not the Shoot
The single most impactful thing you can do is submit your script for MLR review before any production begins. This includes voiceover copy, on-screen text, proposed claims, and reference annotations. A clean script dramatically reduces the chance of reshoots or major re-edits later.
When writing scripts for MLR, keep these principles in mind:
- Separate promotional claims from educational content clearly — reviewers need to see the distinction immediately
- Annotate every claim with its corresponding reference or data source in a companion document
- Flag any patient language or testimonial statements that may need legal pre-clearance
- Avoid implied superiority claims, even in visual metaphors or b-roll choices
Structure Your Supers for Clarity
On-screen text (supers) is one of the most scrutinized elements in pharma video. Fair balance statements, ISI references, and indication language all need to be visible for minimum durations, readable at prescribed font sizes, and positioned so they don't compete with promotional messaging.
"The best compliance teams we work with don't see MLR as a gate — they see it as a creative constraint that makes the work sharper."
— Senior Producer, Pharmhouse Productions
Build Your Timeline Around Review Cycles
One of the biggest sources of frustration in pharma video production is timeline pressure caused by underestimating MLR review. A realistic production timeline should include dedicated windows for:
- Script submission and first-round feedback (typically 5–10 business days)
- Revised script approval before pre-production begins
- Rough cut review with annotated supers and reference documents
- Fine cut review with final graphics, music, and fair balance
- Final approval with deliverable specs confirmed
Building these windows into your project plan from the start avoids the last-minute scramble that leads to compromised creative or missed deadlines.
The Bottom Line
MLR review doesn't have to be the bottleneck in your production process. When compliance is treated as a creative partner rather than a final hurdle, the result is content that's both beautiful and bulletproof — approved faster, with fewer revision cycles, and ready to deploy across every channel your team needs.
If you're planning a video project and want to set it up for smooth MLR approval from the start, we'd love to talk about your approach.
